Potential mechanisms and clinical applications of static magnetic field therapy in glioma

Area of Science:

• Oncology
• Biophysics
• Neurology

Background:

• Gliomas, including glioblastoma (GBM), are aggressive brain cancers with poor prognoses.
• Current treatments for gliomas have limited efficacy and significant toxicity.
• Static magnetic field (SMF) therapy is an emerging, non-invasive modality for cancer treatment.

Purpose of the Study:

• To review the current advancements in SMF therapy for glioma treatment.
• To explore the potential of SMF therapy as a standalone or adjunctive treatment for gliomas.
• To discuss future research directions for optimizing SMF therapy in glioma applications.

Main Methods:

• Review of preclinical studies and emerging clinical data on SMF therapy in glioma models.
• Analysis of proposed mechanisms of action for SMF therapy, including apoptosis induction and modulation of the tumor microenvironment.
• Evaluation of the safety profile and potential side effects of SMF therapy.

Main Results:

• SMF therapy demonstrates antitumor effects in preclinical glioma models.
• Potential mechanisms include apoptosis induction, inhibition of cell proliferation, and TME modulation.
• SMF therapy appears to minimize damage to surrounding healthy brain tissue.

Conclusions:

• SMF therapy presents a promising, non-invasive approach for glioma treatment.
• Further research is crucial to elucidate precise mechanisms, clinical efficacy, and safety.
• Optimizing SMF therapy requires continued investigation into its therapeutic potential.